Drug Type Small molecule drug |
Synonyms NBD-14009 |
Mechanism HIV envelope protein gp120 inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC25H27ClN4O4S |
InChIKeyLHCFQQVKVNALIZ-NRFANRHFSA-N |
CAS Registry2044687-12-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
HIV Infections | Preclinical | US | 01 Nov 2016 |